Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD).

White MK, Leffler M, Rychlec K, Jones C, McSherry C, Walker L, Kosinski M.

Qual Life Res. 2019 Jul 13. doi: 10.1007/s11136-019-02245-2. [Epub ahead of print]

PMID:
31302840
2.

Burden of hereditary transthyretin amyloidosis on quality of life.

Yarlas A, Gertz MA, Dasgupta NR, Obici L, Pollock M, Ackermann EJ, Lovley A, Kessler AS, Patel PA, White MK, Guthrie SD.

Muscle Nerve. 2019 Aug;60(2):169-175. doi: 10.1002/mus.26515. Epub 2019 Jun 13.

PMID:
31093980
3.

Neonatal Chylothoraces: A 10-Year Experience in a Tertiary Neonatal Referral Centre.

White MK, Bhat R, Greenough A.

Case Rep Pediatr. 2019 Mar 13;2019:3903598. doi: 10.1155/2019/3903598. eCollection 2019.

4.
5.

Treatment Tolerability in Patients with Immunoglobulin Light-Chain Amyloidosis.

Rizio AA, White MK, McCausland KL, Quock TP, Guthrie SD, Yokota M, Bayliss MS.

Am Health Drug Benefits. 2018 Nov;11(8):430-437.

6.

Cardiac biomarkers and health-related quality of life in patients with light chain (AL) amyloidosis.

McCausland KL, Quock TP, Rizio AA, Bayliss MS, White MK, Guthrie SD, Sanchorawala V.

Br J Haematol. 2019 Jun;185(5):998-1001. doi: 10.1111/bjh.15693. Epub 2018 Nov 22. No abstract available.

PMID:
30467849
7.

Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder.

Lam RW, Lamy FX, Danchenko N, Yarlas A, White MK, Rive B, Saragoussi D.

Neuropsychiatr Dis Treat. 2018 Oct 29;14:2861-2877. doi: 10.2147/NDT.S175188. eCollection 2018.

8.

Patient-reported treatment-related symptom burden for patients with advanced melanoma in Canada.

Cheung WY, White MK, Bayliss MS, Stroupe A, Lovley A, King-Kallimanis BL, Lasch K.

Support Care Cancer. 2019 Jan;27(1):219-227. doi: 10.1007/s00520-018-4316-9. Epub 2018 Jun 23.

9.

Does perinatal exposure to exogenous oxytocin influence child behavioural problems and autistic-like behaviours to 20 years of age?

Guastella AJ, Cooper MN, White CRH, White MK, Pennell CE, Whitehouse AJO.

J Child Psychol Psychiatry. 2018 Dec;59(12):1323-1332. doi: 10.1111/jcpp.12924. Epub 2018 Apr 27.

PMID:
29701247
10.

A meta-analytic review of measurement equivalence study findings of the SF-36® and SF-12® Health Surveys across electronic modes compared to paper administration.

White MK, Maher SM, Rizio AA, Bjorner JB.

Qual Life Res. 2018 Jul;27(7):1757-1767. doi: 10.1007/s11136-018-1851-2. Epub 2018 Apr 16.

11.

Humanistic burden of disease for patients with advanced melanoma in Canada.

Cheung WY, Bayliss MS, White MK, Stroupe A, Lovley A, King-Kallimanis BL, Lasch K.

Support Care Cancer. 2018 Jun;26(6):1985-1991. doi: 10.1007/s00520-017-4025-9. Epub 2018 Jan 10.

12.

Psychometric validation of the SF-36 Health Survey in light chain amyloidosis: results from community-based and clinic-based samples.

White MK, McCausland KL, Sanchorawala V, Guthrie SD, Bayliss MS.

Patient Relat Outcome Meas. 2017 Dec 7;8:157-167. doi: 10.2147/PROM.S146849. eCollection 2017.

13.

Discovery and characterization of novel trans-spliced products of human polyoma JC virus late transcripts from PML patients.

Saribas AS, DeVoto J, Golla A, Wollebo HS, White MK, Safak M.

J Cell Physiol. 2018 May;233(5):4137-4155. doi: 10.1002/jcp.26219. Epub 2017 Dec 18.

14.

A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time.

Sanchorawala V, McCausland KL, White MK, Bayliss MS, Guthrie SD, Lo S, Skinner M.

Br J Haematol. 2017 Nov;179(3):461-470. doi: 10.1111/bjh.14889. Epub 2017 Aug 29.

15.

Light Chain (AL) Amyloidosis: The Journey to Diagnosis.

McCausland KL, White MK, Guthrie SD, Quock T, Finkel M, Lousada I, Bayliss MS.

Patient. 2018 Apr;11(2):207-216. doi: 10.1007/s40271-017-0273-5.

16.

Structure-based release analysis of the JC virus agnoprotein regions: A role for the hydrophilic surface of the major alpha helix domain in release.

Saribas AS, White MK, Safak M.

J Cell Physiol. 2018 Mar;233(3):2343-2359. doi: 10.1002/jcp.26106. Epub 2017 Aug 28.

17.

CRISPR Editing Technology in Biological and Biomedical Investigation.

White MK, Kaminski R, Young WB, Roehm PC, Khalili K.

J Cell Biochem. 2017 Nov;118(11):3586-3594. doi: 10.1002/jcb.26099. Epub 2017 Jul 4. Review.

18.

Nuclear Magnetic Resonance Structure of the Human Polyoma JC Virus Agnoprotein.

Coric P, Saribas AS, Abou-Gharbia M, Childers W, Condra JH, White MK, Safak M, Bouaziz S.

J Cell Biochem. 2017 Oct;118(10):3268-3280. doi: 10.1002/jcb.25977. Epub 2017 May 3.

19.

Novel AIDS therapies based on gene editing.

Khalili K, White MK, Jacobson JM.

Cell Mol Life Sci. 2017 Jul;74(13):2439-2450. doi: 10.1007/s00018-017-2479-z. Epub 2017 Feb 16. Review.

20.

The DNA damage response promotes polyomavirus JC infection by nucleus to cytoplasm NF- kappaB activation.

White MK, Bellizzi A, Ibba G, Pietropaolo V, Palamara AT, Wollebo HS.

Virol J. 2017 Feb 15;14(1):31. doi: 10.1186/s12985-017-0707-7.

21.

The burden of amyloid light chain amyloidosis on health-related quality of life.

Bayliss M, McCausland KL, Guthrie SD, White MK.

Orphanet J Rare Dis. 2017 Jan 19;12(1):15. doi: 10.1186/s13023-016-0564-2.

22.

Content validation of the SF-36v2® health survey with AL amyloidosis patients.

White MK, Bayliss MS, Guthrie SD, Raymond KP, Rizio AA, McCausland KL.

J Patient Rep Outcomes. 2017;1(1):13. doi: 10.1186/s41687-017-0020-7. Epub 2017 Dec 8.

23.

Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape.

White MK, Hu W, Khalili K.

PLoS Pathog. 2016 Dec 8;12(12):e1005953. doi: 10.1371/journal.ppat.1005953. eCollection 2016 Dec. Review. No abstract available.

24.

Zika virus: An emergent neuropathological agent.

White MK, Wollebo HS, David Beckham J, Tyler KL, Khalili K.

Ann Neurol. 2016 Oct;80(4):479-89. doi: 10.1002/ana.24748. Epub 2016 Aug 10. Review.

25.

Developing, Implementing, and Evaluating a School-Centered Asthma Program: Step-Up Asthma Program.

Liptzin DR, Gleason MC, Cicutto LC, Cleveland CL, Shocks DJ, White MK, Faino AV, Szefler SJ.

J Allergy Clin Immunol Pract. 2016 Sep-Oct;4(5):972-979.e1. doi: 10.1016/j.jaip.2016.04.016. Epub 2016 Jun 7.

PMID:
27283054
26.

Gene Editing for Treatment of Neurological Infections.

White MK, Kaminski R, Wollebo H, Hu W, Malcolm T, Khalili K.

Neurotherapeutics. 2016 Jul;13(3):547-54. doi: 10.1007/s13311-016-0439-1. Review.

27.

HIV-1 Tat and Cocaine Impair Survival of Cultured Primary Neuronal Cells via a Mitochondrial Pathway.

De Simone FI, Darbinian N, Amini S, Muniswamy M, White MK, Elrod JW, Datta PK, Langford D, Khalili K.

J Neuroimmune Pharmacol. 2016 Jun;11(2):358-68. doi: 10.1007/s11481-016-9669-6. Epub 2016 Mar 31.

28.

The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.

Wollebo HS, Bellizzi A, Cossari DH, Salkind J, Safak M, White MK.

J Neurovirol. 2016 Oct;22(5):615-625. Epub 2016 Mar 23.

29.

CRISPR/Cas9 and cancer targets: future possibilities and present challenges.

White MK, Khalili K.

Oncotarget. 2016 Mar 15;7(11):12305-17. doi: 10.18632/oncotarget.7104. Review.

30.

Emerging From the Unknown: Structural and Functional Features of Agnoprotein of Polyomaviruses.

Saribas AS, Coric P, Hamazaspyan A, Davis W, Axman R, White MK, Abou-Gharbia M, Childers W, Condra JH, Bouaziz S, Safak M.

J Cell Physiol. 2016 Oct;231(10):2115-27. doi: 10.1002/jcp.25329. Epub 2016 Feb 24. Review. Erratum in: J Cell Physiol. 2016 Dec;231(12):2789.

31.

GRP78 Interacting Partner Bag5 Responds to ER Stress and Protects Cardiomyocytes From ER Stress-Induced Apoptosis.

Gupta MK, Tahrir FG, Knezevic T, White MK, Gordon J, Cheung JY, Khalili K, Feldman AM.

J Cell Biochem. 2016 Aug;117(8):1813-21. doi: 10.1002/jcb.25481. Epub 2016 Jan 21.

32.

Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.

White MK, Sariyer IK, Gordon J, Delbue S, Pietropaolo V, Berger JR, Khalili K.

Rev Med Virol. 2016 Mar;26(2):102-14. doi: 10.1002/rmv.1866. Epub 2015 Dec 14. Review.

33.

Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy.

Wollebo HS, Cotto B, Adiga R, Langford D, White MK.

Curr HIV Res. 2016;14(1):47-53.

34.

CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection.

Wollebo HS, Bellizzi A, Kaminski R, Hu W, White MK, Khalili K.

PLoS One. 2015 Sep 11;10(9):e0136046. doi: 10.1371/journal.pone.0136046. eCollection 2015.

35.

Animal Models for Progressive Multifocal Leukoencephalopathy.

White MK, Gordon J, Berger JR, Khalili K.

J Cell Physiol. 2015 Dec;230(12):2869-74. doi: 10.1002/jcp.25047. Review.

36.

Degradation of polyomavirus JC T-antigen by stress involves the LIP isoform of C/EBP.

Bellizzi A, White MK, Wollebo HS.

Cell Cycle. 2015;14(13):2075-9. doi: 10.1080/15384101.2015.1042631. Epub 2015 May 27.

37.

The CRISPR/Cas9 genome editing methodology as a weapon against human viruses.

White MK, Hu W, Khalili K.

Discov Med. 2015 Apr;19(105):255-62. Review.

38.

Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.

Wollebo HS, Bellizzi A, Cossari DH, Safak M, Khalili K, White MK.

J Neurovirol. 2015 Dec;21(6):679-87. doi: 10.1007/s13365-015-0326-2. Epub 2015 Mar 20.

39.

Persistence and pathogenesis of the neurotropic polyomavirus JC.

Wollebo HS, White MK, Gordon J, Berger JR, Khalili K.

Ann Neurol. 2015 Apr;77(4):560-70. doi: 10.1002/ana.24371. Epub 2015 Mar 6. Review.

40.

Rad51 activates polyomavirus JC early transcription.

White MK, Kaminski R, Khalili K, Wollebo HS.

PLoS One. 2014 Oct 13;9(10):e110122. doi: 10.1371/journal.pone.0110122. eCollection 2014.

41.

Viruses and human cancers: a long road of discovery of molecular paradigms.

White MK, Pagano JS, Khalili K.

Clin Microbiol Rev. 2014 Jul;27(3):463-81. doi: 10.1128/CMR.00124-13. Review.

42.

Interplay of Rad51 with NF-κB pathway stimulates expression of HIV-1.

Kaminski R, Wollebo HS, Datta PK, White MK, Amini S, Khalili K.

PLoS One. 2014 May 21;9(5):e98304. doi: 10.1371/journal.pone.0098304. eCollection 2014.

43.

Nuclear magnetic resonance structure revealed that the human polyomavirus JC virus agnoprotein contains an α-helix encompassing the Leu/Ile/Phe-rich domain.

Coric P, Saribas AS, Abou-Gharbia M, Childers W, White MK, Bouaziz S, Safak M.

J Virol. 2014 Jun;88(12):6556-75. doi: 10.1128/JVI.00146-14. Epub 2014 Mar 26. Erratum in: J Virol. 2014 Sep;88(18):11000.

44.

Involvement of IRS-1 interaction with ADAM10 in the regulation of neurite extension.

Wang JY, Darbinyan A, White MK, Darbinian N, Reiss K, Amini S.

J Cell Physiol. 2014 Aug;229(8):1039-46. doi: 10.1002/jcp.24528.

45.

Human polyoma JC virus minor capsid proteins, VP2 and VP3, enhance large T antigen binding to the origin of viral DNA replication: evidence for their involvement in regulation of the viral DNA replication.

Saribas AS, Mun S, Johnson J, El-Hajmoussa M, White MK, Safak M.

Virology. 2014 Jan 20;449:1-16. doi: 10.1016/j.virol.2013.10.031. Epub 2013 Nov 12.

46.

TNF-α/NF-κB signaling in the CNS: possible connection to EPHB2.

Pozniak PD, White MK, Khalili K.

J Neuroimmune Pharmacol. 2014 Mar;9(2):133-41. doi: 10.1007/s11481-013-9517-x. Epub 2013 Nov 27. Review.

47.

Reliability and Validity of the Persian HIT-6 Questionnaire in Migraine and Tension-type Headache.

Zandifar A, Banihashemi M, Haghdoost F, Masjedi SS, Manouchehri N, Asgari F, Najafi MR, Ghorbani A, Zandifar S, Saadatnia M, White MK.

Pain Pract. 2014 Sep;14(7):625-31. doi: 10.1111/papr.12120. Epub 2013 Nov 18.

PMID:
24237583
48.

Compartmentalized neuronal cultures.

Darbinyan A, Pozniak P, Darbinian N, White MK, Khalili K.

Methods Mol Biol. 2013;1078:147-52. doi: 10.1007/978-1-62703-640-5_13.

49.

Lentiviral transduction of neuronal cells.

Wollebo HS, Woldemichaele B, White MK.

Methods Mol Biol. 2013;1078:141-6. doi: 10.1007/978-1-62703-640-5_12.

50.

Isolation and propagation of primary human and rodent embryonic neural progenitor cells and cortical neurons.

Darbinyan A, Kaminski R, White MK, Darbinian N, Khalili K.

Methods Mol Biol. 2013;1078:45-54. doi: 10.1007/978-1-62703-640-5_5.

Supplemental Content

Loading ...
Support Center